James E. Flynn, Director: Nuvalent NUVL Sell · Filed 24/10/24

Trade details

Type: Insider sale
Amount: $97,750,000
Shares · price: 1,000,000 sh · $97.75 a share
Held after: 8,670,512 sh
Stock: Nuvalent NUVL
Person: James E. FlynnDirector
Trade date: 24/10/22
Filed: 24/10/24
Days to filing: 2 days

Sold 10.3% of holdings

Share of holding sold: 10.3%

Nuvalent trades, last 26 weeks

What else happened in Nuvalent around then

Filed or reported within 30 days of the trade day · 24/09/22~24/11/21

James E. Flynn's recent trades

James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$10M
2,000,000 sh
$10M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$5.4M
1,084,012 sh
$5.4M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$5.4M
1,084,010 sh
$5.4M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$4.2M
831,978 sh
$4.2M
Filed 03/02
Traded 02/27
James E. FlynnDirector
SellNuvalent
Sell
Nuvalent
NUVL
$35.4M
371,287 sh
$35.4M
Filed 25/11/24
Traded 25/11/24

James E. Flynn, Director — sold $97.8M of Nuvalent NUVL · 10.3% of holdings | Whalegun